ARCHIVES

Why Did DeVita Resign MSK Post? Clash Of Style, Other Serious Issues Pointed To By Colleagues

This article is from The Cancer Letter archive.

Vol. 17 No. 23 | June 7, 1991

Download PDF Visit The Full Archive

Related Articles

Funding Opportunities: NIAID seeks New Investigator, Risky Research Proposals

March 28, 1997

DCT Board Approves $17 Million In Recompetition; Asks Some Be Switched To Cooperative Agreements

November 23, 1979

IOM Reports Says HIPPA Privacy Rule Hinders Research, Doesn’t Protect Patient Privacy

February 6, 2009

ODAC Recommends Approval Of Nplate For Thrombocytopenia.

March 21, 2008

Gleevec First Pediatric Cancer Approval By FDA In 13 Years

May 30, 2003

75% Of Fed Research Funds Pay Direct Costs, Study Says.

July 28, 2000